Preparations of enzymes
Medicaments consisting of enzyme preparations for therapeutic use
HSN 3004 90 84 (Preparations of enzymes) is subject to drug import controls under the Drugs and Cosmetics Act, 1940, with mandatory Central Drugs Standard Control Organisation (CDSCO) registration and import licence as the operative clearance requirements at the bill of entry. The Directorate General of Foreign Trade (DGFT) classifies this tariff line with a specific prohibition on oxytocin, permitting import of oxytocin reference standards exclusively for testing and analysis against a DCGI-issued test licence under S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022.
- Registration certificate from CDSCO
- Import licence for drugs from CDSCO
- Batch release certificate from CDSCO
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.
- 1Obtain a valid drug registration certificate (document code 101dc1) and import licence for drugs (document code 9111dc) from the Central Drugs Standard Control Organisation before the consignment is dispatched. Both documents must be uploaded in e-Sanchit prior to filing the bill of entry.Drugs and Cosmetics Act, 1940 · CDSCO import licensing regime · document codes 101dc1 and 9111dc
- 2Upload the Certificate of Analysis (document code 0010dc), Batch Release Certificate (document code 0030dc), and Label of Consignment (document code 0110dc) in e-Sanchit before the bill of entry is filed. The proper officer will verify these documents before granting out-of-charge.CBIC e-Sanchit requirement · document codes 0010dc, 0030dc, 0110dc
- 3If the enzyme preparation contains oxytocin, note that import is prohibited; import of oxytocin reference standards is permitted solely for test and analysis purposes and requires a test licence issued by DCGI/CDSCO. Ensure the ITC (HS) policy prohibition is confirmed before purchase order placement.S.O. 2357(E) · DGFT Notification 09/2015-2020 dated 23-05-2022
The most common error on this tariff line is conflating the drug registration certificate with the import licence — both are distinct CDSCO instruments with independent validity windows, and absence of either at bill-of-entry stage results in consignment detention. Importers relying on the oxytocin-reference-standard carve-out must ensure the DCGI-issued test licence specifically authorises import for test and analysis; a general drug import licence does not satisfy the S.O. 2357(E) condition and will not secure out-of-charge.